RDIF agrees to produce another 100 million doses of Sputnik V vaccine in India

"RDIF and one of India's leading vaccine and drug manufacturers, Panacea Biotec, are partnering to produce 100 million doses of the world's first registered Sputnik V coronavirus vaccine annually," the report said.

It is noted that the production of the vaccine in India will help supply Sputnik V to RDIF's international partners.

Earlier, RDIF agreed to produce more than 100 million doses of Sputnik V in China per year.